EnteroMedics Quote Page (ETRM)

DJIA	12,454.83	-74.92	-0.60%
NASDAQ	2,837.53	-1.85	-0.07%
S&P 500	1,317.82	-2.86	-0.22%

Obesity: The Next Investment Driver

5/11/2012 by InvestorPlace

Anti-obesity device maker EnteroMedics widens loss

4/24/2012 by Star Tribune - Minneapolis MN

EnteroMedics, Inc. (ETRM) Posts Mixed Q1 Results

4/24/2012 by StreetInsider.com

EnteroMedics reports Q1 EPS (15c), consensus (18c)

4/24/2012 by Theflyonthewall.com

EnteroMedics Reports First Quarter 2012 Financial Results

4/24/2012 by Marketwire

EnteroMedics to Host First Quarter 2012 Financial Results Conference Call and Provide Business Update

4/19/2012 by Marketwire

EnteroMedics strengthens financial position with $20M debt loan; $5M offering

4/17/2012 by Theflyonthewall.com

EnteroMedics Strengthens Financial Position With $20 Million Debt Agreement and $5.0 Million Equity Offering

4/17/2012 by Marketwire

EnteroMedics to host conference call

4/3/2012 by Theflyonthewall.com

EnteroMedics announces 2.5-Year diabetes, hypertension and weight loss data

4/3/2012 by Theflyonthewall.com

EnteroMedics Announces First Commercial Shipment of the Maestro(R) Rechargeable System to Australia

4/3/2012 by StockWatch

EnteroMedics Announces 2.5-Year Diabetes, Hypertension and Weight Loss Data From the Maestro(R) RC System DM2 ENABLE Study

4/3/2012 by StockWatch

EnteroMedics announces 1st commercial shipment of Maestro RC to Australia

4/3/2012 by Theflyonthewall.com

EnteroMedics Announces 2.5-Year Diabetes, Hypertension and Weight Loss Data From the Maestro(R) RC System DM2 ENABLE Study

4/3/2012 by Marketwire

Big executive pay raises at EnteroMedics a year after they took significant cuts

3/21/2012 by Minneapolis / St. Paul Business Journal - Minneapolis MN

EnteroMedics' VBLOC gets new category III CPT codes from The AMA

3/12/2012 by Theflyonthewall.com

American Medical Association Adopts New Category III CPT Codes for Vagus Nerve Blocking Therapy

3/12/2012 by Marketwire

EnteroMedics to Present at the 24th Annual ROTH Capital Growth Conference

3/7/2012 by Marketwire

EnteroMedics to Participate in 4th Annual Lazard Capital Markets Medical Technology Conference

2/21/2012 by Marketwire

Wells Fargo reports 6.36% passive stake in EnteroMedics

1/27/2012 by Theflyonthewall.com

EnteroMedics gets approval for Maestro components

1/26/2012 by Theflyonthewall.com

EnteroMedics reports Q4 EPS (22c) vs. consensus (21c)

1/26/2012 by Theflyonthewall.com

EnteroMedics Reports Fourth Quarter 2011 Financial Results

1/26/2012 by StockWatch

EnteroMedics Reports Fourth Quarter 2011 Financial Results

1/26/2012 by Marketwire

EnteroMedics completes enrolment, device implantation in ReCharge trial

12/28/2011 by Theflyonthewall.com

EnteroMedics Announces Completion of Patient Enrollment and Device Implantation in the ReCharge Pivotal Trial for Obesity

12/28/2011 by StockWatch

EnteroMedics Announces Completion of Patient Enrollment and Device Implantation in the ReCharge Pivotal Trial for Obesity

12/28/2011 by Marketwire

EnteroMedics Receives Australia Approval For The Components Of Maestro System

12/13/2011 by RTTNews

EnteroMedics Receives First Approval for the Active Implantable Medical Device Components of the Maestro System From Australian Therapeutic Goods Administration (TGA)

12/13/2011 by Marketwire

EnteroMedics to Present at the Canaccord Genuity Sixth Annual Cardiovascular, Aesthetics and Metabolic Disorders Conference

11/29/2011 by Marketwire

EnteroMedics to Present at the 23rd Annual Piper Jaffray Healthcare Conference

11/22/2011 by Marketwire

EnteroMedics to Present at the Lazard Capital Markets 8th Annual Healthcare Conference

11/7/2011 by StockWatch

EnteroMedics to Present at the Lazard Capital Markets 8th Annual Healthcare Conference

11/7/2011 by Marketwire

EnteroMedics Inc. Reports Operating Results (10-Q)

11/4/2011 by GuruFocus

EnteroMedics reports Q3 EPS (26c) vs. consensus (27c)

10/20/2011 by Theflyonthewall.com

EnteroMedics, Inc. (ETRM) Posts Narrower than Expected Q3 Loss

10/20/2011 by StreetInsider.com

EnteroMedics Reports Third Quarter 2011 Financial Results

10/20/2011 by Marketwire

EnteroMedics Announces Updated Data From VBLOC DM2 ENABLE Study and Caloric Intake Study Results to Be Presented at the 29th Annual Obesity Society Meeting

10/3/2011 by Marketwire

EnteroMedics to Present at the Craig-Hallum 2nd Annual Alpha Select Conference

9/30/2011 by StockWatch

EnteroMedics to Present at the Craig-Hallum 2nd Annual Alpha Select Conference

9/30/2011 by Marketwire

Ticker

EnteroMedics